Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wheeler

Showing results (571-580 of 599) with videos related to

Pageof 60
Sort By:
Lancet (London, England)|May 4, 2010
Clinical assessment incorporating a personal genomeEuan A Ashley, Atul J Butte, Matthew T Wheeler, et al.
JAMA|February 1, 2022
Prevalence and Cumulative Risk of Familial Idiopathic Dilated CardiomyopathyGordon S Huggins, Daniel D Kinnamon, Garrie J Haas, et al.
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Circulation. Heart Failure|December 10, 2019
Baseline Characteristics of the VANISH CohortAnna Axelsson Raja, Ling Shi, Sharlene M Day, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Nature|November 12, 2025
GREGoR: accelerating genomics for rare diseasesMoez Dawood, Ben Heavner, Marsha M Wheeler, et al.
Plos Genetics|September 22, 2011
Phased whole-genome genetic risk in a family quartet using a major allele reference sequenceFrederick E Dewey, Rong Chen, Sergio P Cordero, et al.
Cell Genomics|October 23, 2023
The functional impact of rare variation across the regulatory cascadeTaibo Li, Nicole Ferraro, Benjamin J Strober, et al.
JAMA|August 1, 2023
Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European AncestryElizabeth Jordan, Daniel D Kinnamon, Garrie J Haas, et al.
The New England Journal of Medicine|October 11, 2018
Effect of Genetic Diagnosis on Patients with Previously Undiagnosed DiseaseKimberly Splinter, David R Adams, Carlos A Bacino, et al.
Pageof 60

Showing results (571-580 of 599) with videos related to

Sort By:
Pageof 60
Lancet (London, England)|May 4, 2010
Clinical assessment incorporating a personal genomeEuan A Ashley, Atul J Butte, Matthew T Wheeler, et al.
JAMA|February 1, 2022
Prevalence and Cumulative Risk of Familial Idiopathic Dilated CardiomyopathyGordon S Huggins, Daniel D Kinnamon, Garrie J Haas, et al.
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Circulation. Heart Failure|December 10, 2019
Baseline Characteristics of the VANISH CohortAnna Axelsson Raja, Ling Shi, Sharlene M Day, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Nature|November 12, 2025
GREGoR: accelerating genomics for rare diseasesMoez Dawood, Ben Heavner, Marsha M Wheeler, et al.
Plos Genetics|September 22, 2011
Phased whole-genome genetic risk in a family quartet using a major allele reference sequenceFrederick E Dewey, Rong Chen, Sergio P Cordero, et al.
Cell Genomics|October 23, 2023
The functional impact of rare variation across the regulatory cascadeTaibo Li, Nicole Ferraro, Benjamin J Strober, et al.
JAMA|August 1, 2023
Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European AncestryElizabeth Jordan, Daniel D Kinnamon, Garrie J Haas, et al.
The New England Journal of Medicine|October 11, 2018
Effect of Genetic Diagnosis on Patients with Previously Undiagnosed DiseaseKimberly Splinter, David R Adams, Carlos A Bacino, et al.
Pageof 60